Abstract:AIM:To determine the lethiferous effects of a recombinant vector carrying thymidine kinase (TK) suicide gene on 2.2.15 cells and the possible self-modulating mechanism.METHODS:A self-modulated expressive plasmid pcDNA3-SCITK was constructed by inserting the fragments carrying hepatitis B virus antisense-S (HBV-anti-S) gene, hepatitis C virus core (HCV-C) gene, internal ribosome entry site (IRES) element of HCV and TK gene into the eukaryotic vector pcDNA3, in which the expression of TK suicide gene was controlled by the HBV S gene transcription. 2.2.15 cells that carry the full HBV genome and stably express series of HBV antigen were transfected with pcDNA3-SCITK or vector pcDNA3-SCI which was used as the mock plasmid. The HepG2 cells transfected with pcDNA3-SCITK were functioned as the negative control. All the transfected cells were incubated in DMEM medium supplemented with 10 microg/ml. of ganciclovir (GCV). The HBsAg levels in the supernatant of cell culture were detected by ELISA on the 1st, 3rd and 6th day post-transfection. Meanwhile, the morphology of transfected cells was recorded by the photograph and the survival cell ratio was assessed by the trypan blue exclusion test on the 6th day post-transfection.RESULTS:The structural accuracy of pcDNA3-SCITK was confirmed by restriction endonuclease digestion, PCR with specific primers and DNA sequencing. The HBsAg levels in the supernatant of transfected 2.2.15 cell culture were significantly decreased on the 6th day post-transfection as compared with that of the mock control (P<0.05). The lethiferous effect of pcDNA3-SCITK expression on 2.2.15 cells was initially noted on the 3rd day after transfection and aggravated on the 6th day post transfection, in which the majority of transfected 2.2.15 cells were observed shrunken, round in shape and even dead. With assessment by the trypan blue exclusion test, the survival cell ratio on the 6th day post transfection was 95% in the negative control and only 11% in the experimental group.CONCLUSION:The results indicate that suicide gene expression of pcDNA3-SCITK can only respond to HBV-S gene transcription, which may be potentially useful in the treatment of HBV infection and its related liver malignancies.

Construction of the Vector That Harbors Self-Restricted System for Hepatitis B Virus Clearance in Gene Therapy

Construction of an Effective Eukaryotic Bi-Cistronic Expression Vector Containg HCV Internal Ribosome Entry Site

Re-Designed Recombinant Hepatitis B Virus Vectors Enable Efficient Delivery of Versatile Cargo Genes to Hepatocytes with Improved Safety.

Construction of the Recombinant Expression Vector Psuper-Hbvs/c for Research of RNAi Against HBV

Construction of eukaryotic expression vector carrying IFN-β gene under control of human HBV promoter

Replication-Competent Infectious Hepatitis B Virus Vectors Carrying Substantially Sized Transgenes By Redesigned Viral Polymerase Translation

Construction of Expression Vector of Truncated C Gene Combined with Pres1 Gene of Hepatitis B Virus and Expression in Eukaryotic Cell

Suppression of Hepatitis B Virus Antigen Production and Replication by Wild-Type HBV Dependently Replicating HBV Shrna Vectors in Vitro and in Vivo.

Construction of Shuttle Expression Vector of Pre-S1 Gene and Truncated Core Gene of Hepatitis B Virus

Construction of Recombinant Retrovirus Vector Carrying Dual Target Antisense RNA of Hepatitis B Virus

Construction and Identification of Small Hairpin RNA Vector Targeting HBV Core Protein in HepG2.2.15 Cells

Stable replication of the EBNA1/OriP-mediated baculovirus vector and its application to anti-HCV gene therapy

Lethiferous Effects of a Recombinant Vector Carrying Thymidine Kinase Suicide Gene on 2.2.15 Cellsviaa Self-Modulating Mechanism

[Construction of a full-genome HCV replicon with self-cleaving double ribozyme sequences and characterization in vitro and in vivo]

Hepatitis B virus as a gene delivery vector activating foreign antigenic T cell response that abrogates viral expression in mouse models.

Construction of a liver targeting gene transfer vector using hepatitis B virus envelope particles and assessment of its function

Inhibition of Hepatitis B Virus by AAV8-Derived CRISPR/SaCas9 Expressed From Liver-Specific Promoters

Construction of a Novel Gene-Viral Therapeutic System CNHK500-hγ

Construction and expression of recombinant eukaryotic expression vector containing hepatitis B virus surface antigen gene

Construction of HBV Infectious Replicon and Its Significance

Novel Recombinant Hepatitis B Virus Vectors Efficiently Deliver Protein and RNA Encoding Genes into Primary Hepatocytes